86.22.Z - Specialist medical practice
72.11.Z - Scientific research and development activities
72.19.Z - Scientific research and development activities
85.59.B - Courses and training for acquiring knowledge, skills, and professional qualifications in non-school forms
86.10.Z - Hospital activities
86.21.Z - General medical practice
86.90.E - Healthcare
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 6,9 | 1 | 3,6 | 255,9 |
EBITDA | 7,1 | 1,1 | 3,7 | 223,3 |
Short time liabilities | 1,5 | 3,8 | 2,8 | -28,3 |
Equity capital | 1,3 | 1 | 6,4 | 513,7 |
Operating profit (EBIT) | 6,9 | 1 | 3,6 | 255,9 |
Assets | 2,8 | 4,9 | 9,1 | 87,3 |
Net profit (loss) | 6,9 | 1 | 3,6 | 255,9 |
Cash | 0,1 | 1,3 | 0,8 | -37,8 |
Liabilities and provisions for liabilities | 1,5 | 3,8 | 2,8 | -28,3 |
Net income from sale | 20,2 | 25,1 | 42,4 | 68,8 |
Working assets | 2,6 | 4,8 | 8,7 | 82,9 |
Depreciation | 0,2 | 0,1 | 0,1 | -44,4 |
% | % | % | p.p. | |
Profitability of capital | 516 | 97,1 | 56,3 | -40,8 |
Equity capital to total assets | 47 | 21,3 | 69,9 | 48,6 |
Gross profit margin | 34 | 4 | 8,5 | 4,5 |
EBITDA Margin | 35 | 4,5 | 8,6 | 4,1 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 27 | 56 | 24 | -32 |
Current financial liquidity indicator | 1.7284862995147705 | 1.2406225204467773 | 3.16394305229187 | 2 |
Net dept to EBITDA | -0.01183304563164711 | -1.127943515777588 | -0.21686136722564697 | 0,9 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane